Please provide your email address to receive an email when new articles are posted on . The machine-learning model successfully identified all eyes with mild NPDR that progressed within 1 year. The ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.

Use of empagliflozin (Jardiance) was not linked to a lower risk of incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase-4 (DPP-4) inhibitors among patients with type 2 ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Proliferative diabetic retinopathy and non-proliferative diabetic retinopathy are stages of diabetic retinopathy. The former is the more severe form that can lead to vision loss. Unmanaged diabetes ...

Building on the success of GLOW1 and with all patients on a 6-month dosing interval, Zenkuda (tarcocimab tedromer) demonstrated superiority to sham with 62.5% of Zenkuda-treated patients achieving a ...

The 4-2-1 rule is a tool that doctors use to diagnose severe cases of diabetic retinopathy, an eye condition affecting people with diabetes that can progress to vision loss. If high blood sugar levels ...

OcuTerra Therapeutics’ investigational eye drops failed to improve disease severity or progression in a phase 2 diabetic retinopathy trial, prompting the Boston-based biotech to look at strategic ...